Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
Raffaele Marfella(University of Campania "Luigi Vanvitelli"), Giuseppe Paolisso(University of Campania "Luigi Vanvitelli"), Emanuela Concetta D’Angelo(Azienda USL di Bologna), Paolo Maggi(Università degli Studi di Enna Kore), Vincenzo Messina(Ospedale Sant'Anna), Carmine Pizzi(Azienda USL di Bologna), Luca Bergamaschi(Ospedale G.B. Morgagni - L.Pierantoni), Pierluigi Viale(Azienda USL di Bologna), Nazzareno Galiè(Azienda USL di Bologna), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Mauro Biffi(University of Bologna), Pasquale Paolisso(CTO Andrea Alesini), Michelangela Barbieri(University of Campania "Luigi Vanvitelli"), Celestino Sardu(University of Campania "Luigi Vanvitelli"), Maria Rosaria Rizzo(University of Campania "Luigi Vanvitelli")
Cited by 138
Related Papers
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC)
|European Heart Journal|2010|2.3k
(untitled)
|European Heart Journal|2004|1k
Risk stratification and medical therapy of pulmonary arterial hypertension
|European Respiratory Journal|2018|834